ATE214280T1 - Steuerung des heilungsprozesses - Google Patents

Steuerung des heilungsprozesses

Info

Publication number
ATE214280T1
ATE214280T1 AT97900852T AT97900852T ATE214280T1 AT E214280 T1 ATE214280 T1 AT E214280T1 AT 97900852 T AT97900852 T AT 97900852T AT 97900852 T AT97900852 T AT 97900852T AT E214280 T1 ATE214280 T1 AT E214280T1
Authority
AT
Austria
Prior art keywords
controlling
wound healing
healing process
control
healing processes
Prior art date
Application number
AT97900852T
Other languages
English (en)
Inventor
Hans-Arne Hannson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE214280T1 publication Critical patent/ATE214280T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Surgery (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Temperature (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Control Of Steam Boilers And Waste-Gas Boilers (AREA)
  • General Induction Heating (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture, Treatment Of Glass Fibers (AREA)
  • Electrotherapy Devices (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT97900852T 1996-01-18 1997-01-16 Steuerung des heilungsprozesses ATE214280T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9600216A SE9600216D0 (sv) 1996-01-18 1996-01-18 Styrning av läkningsprocesser
PCT/SE1997/000057 WO1997025994A1 (en) 1996-01-18 1997-01-16 Control of healing process

Publications (1)

Publication Number Publication Date
ATE214280T1 true ATE214280T1 (de) 2002-03-15

Family

ID=20401098

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97900852T ATE214280T1 (de) 1996-01-18 1997-01-16 Steuerung des heilungsprozesses

Country Status (20)

Country Link
US (1) US6174855B1 (de)
EP (1) EP0874634B1 (de)
JP (2) JP4112006B2 (de)
KR (1) KR19990077331A (de)
CN (1) CN1213309A (de)
AT (1) ATE214280T1 (de)
AU (1) AU701260B2 (de)
BR (1) BR9707005A (de)
CA (1) CA2241983A1 (de)
CZ (1) CZ225098A3 (de)
DE (1) DE69711024T2 (de)
HU (1) HUP9902029A3 (de)
IL (1) IL125375A0 (de)
IS (1) IS4782A (de)
NO (1) NO983295D0 (de)
NZ (1) NZ326003A (de)
PL (1) PL327828A1 (de)
SE (1) SE9600216D0 (de)
TR (1) TR199801365T2 (de)
WO (1) WO1997025994A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9900043D0 (sv) * 1999-01-11 1999-01-11 Astra Ab New use
SE9900070D0 (sv) 1999-01-13 1999-01-13 Astra Ab New use
ES2384099T3 (es) 2001-06-13 2012-06-29 The University Of Sydney Proteína C para cicatrización de heridas
US7202066B2 (en) * 2002-01-29 2007-04-10 Carrington Laboratories, Inc. Combination of a growth factor and a protease enzyme
US7476659B2 (en) 2003-10-21 2009-01-13 Netech, Inc. Liquid composition for bulging mucous membrane for use in endoscopic surgery comprising a chitosan derivative containing carbohydrate chains
US7795205B2 (en) * 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
US8414907B2 (en) 2005-04-28 2013-04-09 Warsaw Orthopedic, Inc. Coatings on medical implants to guide soft tissue healing
US9119901B2 (en) 2005-04-28 2015-09-01 Warsaw Orthopedic, Inc. Surface treatments for promoting selective tissue attachment to medical impants
US7450296B2 (en) 2006-01-30 2008-11-11 Taiwan Semiconductor Manufacturing Company, Ltd. Method and system for patterning alignment marks on a transparent substrate
EP2023874A4 (de) * 2006-06-02 2009-07-08 Bioseek Inc Verfahren zur identifizierung von wirkstoffen und ihre verwendung zur prävention von restenose
AU2012252165A1 (en) 2011-05-09 2013-03-21 Cambridge Enterprise Limited Methods of modulating micrornas in the treatment of pulmonary arterial hypertension
DE102014112212A1 (de) 2014-08-26 2016-03-03 Akesion Gmbh Rekombinante Fusionsproteine zur Vorbeugung oder Behandlung von Adhäsionen bei Geweben oder Organen
WO2018089248A2 (en) * 2016-11-02 2018-05-17 Tucker Erik L E-we thrombin analog and fibrinolytic combination
CN106729676A (zh) * 2016-12-07 2017-05-31 杭州市萧山区中医院 水蛭素用于制备治疗术后肌腱粘连的药物中的应用
JP7264589B2 (ja) * 2017-12-25 2023-04-25 株式会社 資生堂 トロンビンの抑制作用を指標とした皮膚状態改善剤のスクリーニング方法、及びトロンビン作用阻害剤を含む皮膚状態改善剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4326532A (en) * 1980-10-06 1982-04-27 Minnesota Mining And Manufacturing Company Antithrombogenic articles
US4532134A (en) * 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
JPS61253065A (ja) 1985-05-02 1986-11-10 片倉チツカリン株式会社 キトサン誘導体およびコラ−ゲンの複合材の医用材料およびその製造法
US5112608A (en) * 1987-03-13 1992-05-12 Incyte Pharmaceuticals Use of protease nexin-I to mediate wound healing
NL8902406A (nl) * 1989-09-27 1991-04-16 Hendrik Coenraad Hemker Prof D Werkwijze voor het bepalen van de endogene trombinepotentiaal van plasma, en bloed alsmede een bij deze werkwijze te gebruiken kit.
DE69015775T2 (de) * 1989-10-31 1995-05-11 Howmedica Chitinderivate enthaltende Zusammensetzungen zur Verhütung der Adhäsion.
US5209776A (en) 1990-07-27 1993-05-11 The Trustees Of Columbia University In The City Of New York Tissue bonding and sealing composition and method of using the same
JPH04112006A (ja) * 1990-08-31 1992-04-14 Seiji Ichikawa セメント液作成方法
US5792835A (en) * 1991-09-05 1998-08-11 Baxter International Inc. Method of preparing a topical fibrinogen complex
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
DE4200080A1 (de) 1992-01-03 1993-09-30 Reinmueller Johannes Pharmazeutische Zusammensetzung zur Wund-, Narben- und Keloidbehandlung
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives

Also Published As

Publication number Publication date
TR199801365T2 (xx) 1998-10-21
WO1997025994A1 (en) 1997-07-24
AU1327197A (en) 1997-08-11
DE69711024D1 (de) 2002-04-18
EP0874634A1 (de) 1998-11-04
CN1213309A (zh) 1999-04-07
AU701260B2 (en) 1999-01-21
IL125375A0 (en) 1999-03-12
CZ225098A3 (cs) 1998-10-14
BR9707005A (pt) 1999-07-20
HUP9902029A2 (hu) 1999-11-29
HUP9902029A3 (en) 2001-01-29
NO983295L (no) 1998-07-16
EP0874634B1 (de) 2002-03-13
SE9600216D0 (sv) 1996-01-18
JP2000503318A (ja) 2000-03-21
CA2241983A1 (en) 1997-07-24
NZ326003A (en) 2001-03-30
US6174855B1 (en) 2001-01-16
IS4782A (is) 1998-06-24
NO983295D0 (no) 1998-07-16
KR19990077331A (ko) 1999-10-25
PL327828A1 (en) 1999-01-04
JP4112006B2 (ja) 2008-07-02
DE69711024T2 (de) 2002-09-19
JP2008163036A (ja) 2008-07-17

Similar Documents

Publication Publication Date Title
ATE214280T1 (de) Steuerung des heilungsprozesses
EP1273298A3 (de) Ritonavir in Kombination mit einem zusätzlichen HIV-Proteasehemmer zur Behandlung von AIDS
NZ515567A (en) Method for treating chronic pain using MEK inhibitors
IL131348A0 (en) Treatment and prevention of adhesions
IL135921A (en) Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
WO2000061167A3 (en) TREATMENT OF MYELOMA BONE DISEASE WITH PROTEASOMAL AND NF-λB ACTIVITY INHIBITORS
EP1776954A3 (de) Verwendung von Hemmern des Renin-Angiotensinsystems zur Behandlung von Schlaganfällen
IL110943A (en) Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
YU82602A (sh) Korišćenje il-18 inhibitora za lečenje i/ili prevenciju ateroskleroze
NZ332096A (en) Alpha-hydroxylic acid derivatives their production and use in treating conditions requiring endothelin inhibition
ATE318141T1 (de) Verwendung von taurolidin oder taurultam zur herstellung eines arzneimittels zur vorbeugung von metastasen
WO2002028434A3 (en) Use of a ppar delta activator for treating inflammatory conditions
AU1023497A (en) Tissue factor - kunitz domain fusion proteins as factor viia inhibitors
WO1996040743A3 (en) Inhibitors of factor xa
EP0870502A3 (de) Verwendung von Adenosinaufnahmeinhibitoren zur Herstellung eines Arzneimittels zur Behandlung von Pankreatitis
NO20030841L (no) En ny spesifikk mekanisme for inhibering av blodplateadhesjon til kollagen
AU5986498A (en) Use of aminothiazoles for treating wounds and skin
AU1569700A (en) Novel therapeutic application of low molecular weight heparin
IS5231A (is) Vefjaþáttur sem hefur áhrif á blóðæðarmyndun
AU2001277612A1 (en) Adhesive dressings for the treatment and prophylaxis of scars
WO2000015250A3 (en) Fibroblast inhibitor
WO2002005796A3 (en) Use of a spla2 inhibitor for the treatment of sepsis
DK0895478T3 (da) Bestanddel B som ardanner
MX9801622A (es) Biomateriales comprendidos de derivados de acido hialuronico para prevenir las adhesiones post-quirurgicas.
AU2523601A (en) Benzophenone alpha-d-glycopyranosides, preparation and therapeutic use

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties